{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:37:14Z","timestamp":1792427834974,"version":"4.5.0"},"reference-count":119,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Herpes simplex virus (HSV) keratitis is one of the leading causes of blindness worldwide. Additionally, up to 90% of the population in some countries is seropositive for HSV. HSV can cause a wide spectrum of ocular disease ranging from blepharitis to retinitis. Although the initial clinical expressions of HSV-1 and HSV-2 are similar, HSV-2 has been reported more frequently in association with recurrent HSV disease. Besides irreversible vision loss from keratitis, HSV also causes encephalitis and genital forms of the disease. Despite these statistics, there remains no vaccine against HSV. Current treatment therapies for related ocular diseases include the use of oral and topical antivirals and topical corticosteroids. While effective in many cases, they fail to address the latency and elimination of the virus, making it ineffective in addressing recurrences, a factor which increases the risk of vision loss. As such, there is a need for continued research of other potential therapeutic targets. This review utilized several published articles regarding the manifestations of HSV keratitis, antiviral immune responses to HSV infection, and clinical management of HSV keratitis. This review will summarize the current knowledge on the host\u2013virus interaction in HSV infections, as well as highlighting the current and potential antiviral therapeutics.<\/jats:p>","DOI":"10.3390\/diagnostics12102368","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T21:03:10Z","timestamp":1664485390000},"page":"2368","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Clinical Management of Herpes Simplex Virus Keratitis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6862-0079","authenticated-orcid":false,"given":"Bisant A.","family":"Labib","sequence":"first","affiliation":[{"name":"Pennsylvania College of Optometry, Salus University, Elkins Park, PA 19027, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4321-2735","authenticated-orcid":false,"given":"DeGaulle I.","family":"Chigbu","sequence":"additional","affiliation":[{"name":"Pennsylvania College of Optometry, Salus University, Elkins Park, PA 19027, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/infdis\/jit458","article-title":"Seroprevalence of Herpes Simplex Virus Types 1 and 2--United States, 1999\u20132010","volume":"209","author":"Bradley","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1128\/JCM.00180-06","article-title":"Prevalence of Antibodies against Herpes Simplex Virus Types 1 and 2 in Children and Young People in an Urban Region in Tanzania","volume":"44","author":"Kasubi","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Looker, K.J., Magaret, A.S., May, M.T., Turner, K.M.E., Vickerman, P., Gottlieb, S.L., and Newman, L.M. (2015). Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140765"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Looker, K.J., Magaret, A.S., Turner, K.M.E., Vickerman, P., Gottlieb, S.L., and Newman, L.M. (2015). Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128615"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","article-title":"Herpes Simplex Epithelial and Stromal Keratitis: An Epidemiologic Update","volume":"57","author":"Farooq","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/archophthalmol.2010.187","article-title":"Incidence, Recurrence, and Outcomes of Herpes Simplex Virus Eye Disease in Olmsted County, Minnesota, 1976\u20132007","volume":"128","author":"Young","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003226-200101000-00001","article-title":"Herpes Simplex Virus Epidemiology and Ocular Importance","volume":"20","author":"Liesegang","year":"2001","journal-title":"Cornea"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"108455","DOI":"10.1016\/j.exer.2021.108455","article-title":"Systemic diseases and the cornea","volume":"204","author":"Shah","year":"2021","journal-title":"Exp. Eye Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"722748","DOI":"10.3389\/fmicb.2021.722748","article-title":"Harringtonine Inhibits Herpes Simplex Virus Type 1 Infection by Reducing Herpes Virus Entry Mediator Expression","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archopht.121.1.108","article-title":"Prevention of herpes simplex virus eye disease: A cost-effectiveness analysis","volume":"121","author":"Lairson","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-virology-092917-043457","article-title":"Antiviral Approaches for the Treatment of Herpes Simplex Virus Infections in Newborn Infants","volume":"5","author":"Poole","year":"2018","journal-title":"Annu. Rev. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/JVI.01139-08","article-title":"Herpes Simplex Virus Replication: Roles of Viral Proteins and Nucleoporins in Capsid-Nucleus Attachment","volume":"83","author":"Copeland","year":"2009","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jmv.20365","article-title":"Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay","volume":"76","author":"Corey","year":"2005","journal-title":"J. Med. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e00590-18","DOI":"10.1128\/mSphere.00590-18","article-title":"Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population","volume":"4","author":"Akhtar","year":"2019","journal-title":"mSphere"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1111\/j.1742-4658.2009.07402.x","article-title":"Viral entry mechanisms: Cellular and viral mediators of herpes simplex virus entry","volume":"276","author":"Akhtar","year":"2009","journal-title":"FEBS J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s13365-017-0521-4","article-title":"HSV-1 interaction to 3-O-sulfated heparan sulfate in mouse-derived DRG explant and profiles of inflammatory markers during virus infection","volume":"23","author":"Sharthiya","year":"2017","journal-title":"J. NeuroVirology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-3-319-53168-7_3","article-title":"Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease","volume":"223","author":"Orzalli","year":"2017","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/emboj\/18.2.480","article-title":"HCF-dependent nuclear import of VP16","volume":"18","author":"Hughes","year":"1999","journal-title":"EMBO J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1574-6976.2011.00320.x","article-title":"The molecular basis of herpes simplex virus latency","volume":"36","author":"Nicoll","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2009.07.007","article-title":"Functional roles of the tegument proteins of herpes simplex virus type 1","volume":"145","author":"Kelly","year":"2009","journal-title":"Virus Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"14516","DOI":"10.1128\/JVI.79.23.14516-14525.2005","article-title":"Herpes Simplex Virus 1 Immediate-Early and Early Gene Expression during Reactivation from Latency under Conditions That Prevent Infectious Virus Production","volume":"79","author":"Pesola","year":"2005","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kobiler, O., and Weitzman, M.D. (2019). Herpes simplex virus replication compartments: From naked release to recombining together. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007714"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3389\/fmicb.2016.00869","article-title":"Herpesvirus Late Gene Expression: A Viral-Specific Pre-initiation Complex Is Key","volume":"7","author":"Gruffat","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08820530802111085","article-title":"Ocular HSV-1 Latency, Reactivation and Recurrent Disease","volume":"23","author":"Toma","year":"2008","journal-title":"Semin. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7586","DOI":"10.1128\/jvi.68.11.7586-7590.1994","article-title":"Analysis of the contributions of herpes simplex virus type 1 membrane proteins to the induction of cell-cell fusion","volume":"68","author":"Bell","year":"1994","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-319-53168-7_2","article-title":"Herpes simplex virus Membrane Fusion","volume":"223","author":"Weed","year":"2017","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"ref_27","first-page":"149135","article-title":"Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections","volume":"2012","author":"Chentoufi","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1631\/jzus.B1600460","article-title":"Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection","volume":"18","author":"Zhang","year":"2017","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Nicoll, M.P., Hann, W., Shivkumar, M., Harman, L.E.R., Connor, V., Coleman, H.M., Proen\u00e7a, J., and Efstathiou, S. (2016). The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected Neurons. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005539"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1128\/JVI.01791-10","article-title":"The Herpes Simplex Virus Type 1 Latency-Associated Transcript Can Protect Neuron-Derived C1300 and Neuro2A Cells from Granzyme B-Induced Apoptosis and CD8 T-Cell Killing","volume":"85","author":"Jiang","year":"2011","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/v1030979","article-title":"Innate and Adaptive Immune Responses to Herpes Simplex Virus","volume":"1","author":"Chew","year":"2009","journal-title":"Viruses"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-9255-11-3","article-title":"Expression and activation of toll-like receptor 3 and toll-like receptor 4 on human corneal epithelial and conjunctival fibroblasts","volume":"11","author":"Erdinest","year":"2014","journal-title":"J. Inflamm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1128\/JVI.80.10.5059-5064.2006","article-title":"Double-stranded rna is produced by positive-strand rna viruses and DNA viruses but not in detectable amounts by negative-strand rna viruses","volume":"80","author":"Weber","year":"2006","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2567.2005.02258.x","article-title":"Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells","volume":"117","author":"Kumar","year":"2005","journal-title":"Immunology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cell.2010.01.041","article-title":"SnapShot: Pathways of Antiviral Innate Immunity","volume":"140","author":"Sun","year":"2010","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.cr.7310019","article-title":"Antiviral innate immunity pathways","volume":"16","author":"Seth","year":"2006","journal-title":"Cell Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.00022-07","article-title":"Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3","volume":"21","author":"Vercammen","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lee, I., Bos, S., Li, G., Wang, S., Gadea, G., Despr\u00e8s, P., and Zhao, R.Y. (2018). Probing Molecular Insights into Zika Virus\u2013Host Interactions. Viruses, 10.","DOI":"10.20944\/preprints201804.0063.v1"},{"key":"ref_40","first-page":"204","article-title":"Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6","volume":"439","author":"Redecke","year":"2005","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Labib, B.A., and Chigbu, D.I. (2022). Pathogenesis and Manifestations of Zika Virus-Associated Ocular Diseases. Trop. Med. Infect. Dis., 7.","DOI":"10.3390\/tropicalmed7060106"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I Interferons in Host Defense","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8909","DOI":"10.1128\/JVI.75.19.8909-8916.2001","article-title":"Activation of Interferon Response Factor-3 in Human Cells Infected with Herpes Simplex Virus Type 1 or Human Cytomegalovirus","volume":"75","author":"Preston","year":"2001","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000341680","article-title":"NK Cells in Hepatitis C: Role in Disease Susceptibility and Therapy","volume":"30","author":"Lunemann","year":"2012","journal-title":"Dig. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Chigbu, D., Loonawat, R., Sehgal, M., Patel, D., and Jain, P. (2019). Hepatitis C Virus Infection: Host\u2013Virus Interaction and Mechanisms of Viral Persistence. Cells, 8.","DOI":"10.3390\/cells8040376"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.19.1.65","article-title":"Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse","volume":"19","author":"Guidotti","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or Adaptive Immunity? The Example of Natural Killer Cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1084\/jem.20011149","article-title":"Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells","volume":"195","author":"Ferlazzo","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3389\/fimmu.2019.00512","article-title":"The Role of T Cells in Herpes Stromal Keratitis","volume":"10","author":"Rajasagi","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_52","first-page":"2607","article-title":"Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: No evidence for autoreactive T cells","volume":"41","author":"Verjans","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.4049\/jimmunol.1003735","article-title":"Defining the Herpes Simplex Virus-Specific CD8+T Cell Repertoire in C57BL\/6 Mice","volume":"186","author":"Leger","year":"2011","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fimmu.2020.00766","article-title":"Pathogenesis of Herpes Stromal Keratitis: Immune Inflammatory Response Mediated by Inflammatory Regulators","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"714821","DOI":"10.3389\/fimmu.2021.714821","article-title":"Fas\/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation","volume":"12","author":"Krzyzowska","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.imbio.2013.08.002","article-title":"Fas\/FasL pathway participates in resolution of mucosal inflammatory response early during HSV-2 infection","volume":"219","author":"Krzyzowska","year":"2014","journal-title":"Immunobiology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10495-006-0330-3","article-title":"Herpes simplex virus blocks apoptosis by precluding mitochondrial cytochrome c release independent of caspase activation in infected human epithelial cells","volume":"12","author":"Aubert","year":"2007","journal-title":"Apoptosis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.4049\/jimmunol.167.7.3928","article-title":"HSV and Glycoprotein J Inhibit Caspase Activation and Apoptosis Induced by Granzyme B or Fas","volume":"167","author":"Jerome","year":"2001","journal-title":"J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1128\/JVI.02701-06","article-title":"Herpes Simplex Virus Latency-Associated Transcript Sequence Downstream of the Promoter Influences Type-Specific Reactivation and Viral Neurotropism","volume":"81","author":"Bertke","year":"2007","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1128\/JVI.79.14.9019-9025.2005","article-title":"Herpes Simplex Virus Type 1 Latency-Associated Transcript Expression Protects Trigeminal Ganglion Neurons from Apoptosis","volume":"79","author":"Branco","year":"2005","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/bjo.71.9.669","article-title":"Recurrent herpes simplex virus ocular infection: Epidemiological and clinical features","volume":"71","author":"Wishart","year":"1987","journal-title":"Br. J. Ophthalmol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jtos.2018.10.002","article-title":"Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation","volume":"17","author":"Lobo","year":"2019","journal-title":"Ocul. Surf."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/bjophthalmol-2012-302294","article-title":"Optical aberrations in patients with recurrent herpes simplex keratitis and apparently normal vision","volume":"97","author":"Kaswin","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/s41433-020-01153-x","article-title":"Update on Herpes simplex keratitis management","volume":"34","author":"Sibley","year":"2020","journal-title":"Eye"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2018.04.003","article-title":"Neurotrophic keratopathy","volume":"66","author":"Dua","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.preteyeres.2012.08.002","article-title":"Herpes keratitis","volume":"32","author":"Rowe","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.micinf.2005.03.003","article-title":"Early events in HSV keratitis\u2014Setting the stage for a blinding disease","volume":"7","author":"Biswas","year":"2005","journal-title":"Microbes Infect."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41587-020-00781-8","article-title":"Targeting herpes simplex virus with CRISPR\u2013Cas9 cures herpetic stromal keratitis in mice","volume":"39","author":"Yin","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2015.02.012","article-title":"Corneal Angiography for Guiding and Evaluating Fine-Needle Diathermy Treatment of Corneal Neovascularization","volume":"122","author":"Spiteri","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_70","first-page":"CD002898","article-title":"Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis","volume":"1","author":"Wilhelmus","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0039-6257(76)90084-9","article-title":"Historical observations on herpetic keratitis","volume":"21","author":"Thygeson","year":"1976","journal-title":"Surv. Ophthalmol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archopht.1989.01070020226030","article-title":"Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982","volume":"107","author":"Liesegang","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/ICO.0000000000001316","article-title":"Self-Retained Amniotic Membrane Combined With Antiviral Therapy for Herpetic Epithelial Keratitis","volume":"36","author":"Cheng","year":"2017","journal-title":"Cornea"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/ICO.0b013e3181a2a7f6","article-title":"Autologous Serum 50% Eyedrops in the Treatment of Persistent Corneal Epithelial Defects","volume":"28","author":"Jeng","year":"2009","journal-title":"Cornea"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2019.08.020","article-title":"Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial","volume":"127","author":"Pflugfelder","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/OPTH.S80475","article-title":"Herpes simplex keratitis: Challenges in diagnosis and clinical management","volume":"11","author":"Azher","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2147\/OPTH.S92517","article-title":"Mapping of dendritic lesions in patients with herpes simplex keratitis using in vivo confocal microscopy","volume":"9","author":"Kobayashi","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ajo.2005.10.056","article-title":"Rose Bengal and Lissamine Green Inhibit Detection of Herpes Simplex Virus by PCR","volume":"141","author":"Seitzman","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/092739490500363","article-title":"Human herpes simplex virus keratitis: The pathogenesis revisited","volume":"12","author":"Remeijer","year":"2004","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","article-title":"Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: Fine-needle vessel coagulation combined with anti-VEGFs","volume":"31","author":"Koenig","year":"2012","journal-title":"Cornea"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/j.1875-9114.1983.tb03274.x","article-title":"Acyclovir: Mechanism of Action, Pharmacokinetics, Safety and Clinical Applications","volume":"3","author":"Gnann","year":"1983","journal-title":"Pharmacotherapy"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/infdis\/jit350","article-title":"Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis","volume":"208","author":"Osterhaus","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0161-6420(13)31155-5","article-title":"Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis","volume":"101","author":"Barron","year":"1994","journal-title":"Ophthalmology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/135965350701200608","article-title":"Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet","volume":"12","author":"Bonnafous","year":"2007","journal-title":"Antivir. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1099\/0022-1317-64-3-523","article-title":"Characterization of Abnormal Thymidine Kinases Induced by Drug-resistant Strains of Herpes Simplex Virus Type 1","volume":"64","author":"Larder","year":"1983","journal-title":"J. Gen. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjo.68.3.192","article-title":"Pharmacokinetics of oral acyclovir (Zovirax) in the eye","volume":"68","author":"Hung","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0161-6420(94)31087-6","article-title":"Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis","volume":"101","author":"Wilhelmus","year":"1994","journal-title":"Ophthalmology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004170050257","article-title":"Treatment of HSV-1 stromal keratitis with topical cyclosporin A: A pilot study","volume":"237","author":"Heiligenhaus","year":"1999","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajo.2005.11.042","article-title":"Treatment of Herpes Simplex Virus Stromal Keratitis Unresponsive to Topical Prednisolone 1% With Topical Cyclosporine 0.05%","volume":"141","author":"Rao","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.antiviral.2017.11.012","article-title":"A new promising candidate to overcome drug resistant herpes simplex virus infections","volume":"149","author":"Zinser","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A Programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0402-386","article-title":"Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease","volume":"8","author":"Crute","year":"2002","journal-title":"Nat. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm0402-392","article-title":"New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease","volume":"8","author":"Kleymann","year":"2002","journal-title":"Nat. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"eaan5861","DOI":"10.1126\/scitranslmed.aan5861","article-title":"An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye","volume":"10","author":"Jaishankar","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMoa1301150","article-title":"Helicase\u2013Primase Inhibitor Pritelivir for HSV-2 Infection","volume":"370","author":"Wald","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ophtha.2014.03.038","article-title":"Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: The I-CAN study","volume":"121","author":"Cursiefen","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Van Diemen, F.R., Kruse, E.M., Hooykaas, M.J.G., Bruggeling, C.E., Sch\u00fcrch, A.C., van Ham, P.M., Imhof, S.M., Nijhuis, M., Wiertz, E.J.H.J., and jan Lebbink, R. (2016). CRISPR\/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005701"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/s41467-019-10366-y","article-title":"Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice","volume":"10","author":"Dash","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e88468","DOI":"10.1172\/jci.insight.88468","article-title":"In vivo disruption of latent HSV by designer endonuclease therapy","volume":"1","author":"Aubert","year":"2016","journal-title":"JCI Insight"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/s41467-020-17936-5","article-title":"Gene editing and elimination of latent herpes simplex virus in vivo","volume":"11","author":"Aubert","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"B\u0151sze, S., Zsila, F., Biri-Kov\u00e1cs, B., Szeder, B., Majer, Z., Hudecz, F., and Uray, K. (2020). Tailoring Uptake Efficacy of HSV-1 gD Tailoring Uptake Efficacy of Hsv-1 GD Derived Carrier Peptides. Biomolecules, 10.","DOI":"10.3390\/biom10050721"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Gim\u00e9nez, F., Mulik, S., Veiga-Parga, T., Bhela, S., and Rouse, B.T. (2015). Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141925"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(06)69558-5","article-title":"Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: A randomised trial","volume":"368","author":"Vora","year":"2006","journal-title":"Lancet"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"13699","DOI":"10.1074\/jbc.M115.694422","article-title":"Thiopurine Prodrugs Mediate Immunosuppressive Effects by Interfering with Rac1 Protein Function","volume":"291","author":"Shin","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e0064621","DOI":"10.1128\/Spectrum.00646-21","article-title":"6-Thioguanine Inhibits Herpes Simplex Virus 1 Infection of Eyes","volume":"9","author":"Chen","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000091662","article-title":"6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party","volume":"73","author":"Reinisch","year":"2006","journal-title":"Digestion"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drudis.2018.09.001","article-title":"A well-tolerated and rapidly acting thiopurine for IBD?","volume":"24","author":"Florin","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1248\/bpb.b21-00054","article-title":"NSC23766 and Ehop016 Suppress Herpes Simplex Virus-1 Replication by Inhibiting Rac1 Activity","volume":"44","author":"Zhang","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1128\/AAC.01467-12","article-title":"Inhibition of Chikungunya Virus Replication by Harringtonine, a Novel Antiviral That Suppresses Viral Protein Expression","volume":"57","author":"Kaur","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10126-017-9785-1","article-title":"Identification of Inhibitory Compounds Against Singapore Grouper Iridovirus Infection by Cell Viability-Based Screening Assay and Droplet Digital PCR","volume":"20","author":"Jia","year":"2018","journal-title":"Mar. Biotechnol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12275-019-8514-z","article-title":"Anti-varicella-zoster virus activity of cephalotaxine esters in vitro","volume":"57","author":"Kim","year":"2018","journal-title":"J. Microbiol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Lai, Z.-Z., Ho, Y.-J., and Lu, J.-W. (2020). Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms. Molecules, 25.","DOI":"10.3390\/molecules25184082"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.micinf.2018.04.007","article-title":"On the role of retinoic acid in virus induced inflammatory response in cornea","volume":"20","author":"Jaggi","year":"2018","journal-title":"Microbes Infect."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e02367-16","DOI":"10.1128\/JVI.02367-16","article-title":"Azacytidine Treatment Inhibits the Progression of Herpes Stromal Keratitis by Enhancing Regulatory T Cell Function","volume":"91","author":"Varanasi","year":"2017","journal-title":"J. Virol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1167\/iovs.16-20668","article-title":"Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy","volume":"58","author":"Edwards","year":"2017","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.exer.2017.06.015","article-title":"PEDF plus DHA modulate inflammation and stimulate nerve regeneration after HSV-1 infection","volume":"161","author":"He","year":"2017","journal-title":"Exp. Eye Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1189\/jlb.3HI1216-511RR","article-title":"Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology","volume":"102","author":"Rajasagi","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ajpath.2014.12.021","article-title":"Role of miR-155 in the Pathogenesis of Herpetic Stromal Keratitis","volume":"185","author":"Bhela","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajpath.2012.04.014","article-title":"Role of miR-132 in Angiogenesis after Ocular Infection with Herpes Simplex Virus","volume":"181","author":"Mulik","year":"2012","journal-title":"Am. J. Pathol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/10\/2368\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:41:59Z","timestamp":1760143319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/10\/2368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":119,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["diagnostics12102368"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12102368","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}